Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A OXBRIDGE RE HOLDINGS Filed by: MARTIN ALLAN S.

April 17, 2026 11:23 AM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 154,491 ordinary shares held by Allan S Martin and 29,401 ordinary shares held by Allan S. Martin and his wife, Marie Martin, jointly; 83,300 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and 175,998 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and his wife, Marie Martin, jointly, that are currently exercisable; 68,770 ordinary shares held by Fleur de Lis Partners, LLLP, and 249,000 ordinary shares issuable upon the exercise of warrants held by Fleur de Lis Partners, LLLP that are currently exercisable. As the general partner of Fleur de Lis Partners, LLLP, Mr. Martin has voting and investment power over the ordinary shares and warrants held by that entity. Based upon an aggregate of 8,172,420 Issuer ordinary shares of outstanding, consisting of (i) 7,664,122 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 508,298 shares of ordinary shares that may be acquired by exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 29,401 ordinary shares held by Allan S. Martin and Marie Martin, jointly; 175,998 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and Marie Martin, jointly, that are currently exercisable. This amount also includes 8,666 shares held by the Allan S Martin Childrens IRRV Trust and 8,666 ordinary shares issuable upon the exercise of warrants held by the Allan S Martin Childrens IRRV Trust that are currently exercisable. Ms. Martin is the sole Trustee for the Trust. Based upon an aggregate of 7,848,786 Issuer ordinary shares of outstanding, consisting of (i) 7,664,122 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 184,664 shares of ordinary shares able to be acquired upon exercise of warrants


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 68,770 ordinary shares held by Fleur de Lis Partners, LLLP, and 249,000 ordinary shares issuable upon the exercise of warrants held by Fleur de Lis Partners, LLLP that are currently exercisable Based upon an aggregate of 7,913,122 Issuer ordinary shares of outstanding, consisting of (i) 7,664,122 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 249,000 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 8,666 shares held by the Allan S Martin Childrens IRRV Trust; and 8,666 ordinary shares issuable upon the exercise of warrants held by the Allan S Martin Childrens IRRV Trust that are currently exercisable. Ms. Martin is the sole trustee of the Trust. Based upon an aggregate of 7,672,788 Issuer ordinary shares of outstanding, consisting of (i) 7,664,122 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 8,666 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D


MARTIN ALLAN S.
Signature:/s/ Allan S. Martin
Name/Title:Individually
Date:04/17/2026
Marie B. Martin
Signature:/s/ Marie B. Martin
Name/Title:Individually
Date:04/17/2026
Fleur de Lis Partners, LLLP
Signature:/s/ Allan S. Martin
Name/Title:General Partner
Date:04/17/2026
Allan S Martin Childrens IRRV Trust
Signature:/s/ Marie Martin
Name/Title:Trustee
Date:04/17/2026

ATTACHMENTS / EXHIBITS

POWER OF ATTORNEY

Categories

SEC Filings